avrg: GSE58827: Dynamics of the Mouse Liver
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr2_+_131186942 Show fit | 3.59 |
ENSMUST00000028804.8
ENSMUST00000079857.8 |
cell division cycle 25B |
|
chr16_-_42340595 Show fit | 2.90 |
ENSMUST00000102817.4
|
growth associated protein 43 |
|
chr9_-_20959785 Show fit | 2.27 |
ENSMUST00000177754.1
|
DNA methyltransferase (cytosine-5) 1 |
|
chr6_-_67037399 Show fit | 1.95 |
ENSMUST00000043098.6
|
growth arrest and DNA-damage-inducible 45 alpha |
|
chrX_-_142966709 Show fit | 1.95 |
ENSMUST00000041317.2
|
Alport syndrome, mental retardation, midface hypoplasia and elliptocytosis chromosomal region gene 1 |
|
chrX_+_106027300 Show fit | 1.90 |
ENSMUST00000055941.6
|
ATPase, Cu++ transporting, alpha polypeptide |
|
chr12_+_24831583 Show fit | 1.88 |
ENSMUST00000110942.3
ENSMUST00000078902.6 |
membrane bound O-acyltransferase domain containing 2 |
|
chr9_+_70678950 Show fit | 1.79 |
ENSMUST00000067880.6
|
a disintegrin and metallopeptidase domain 10 |
|
chr4_+_132074697 Show fit | 1.65 |
ENSMUST00000094662.1
|
predicted gene 10300 |
|
chr6_-_56901870 Show fit | 1.61 |
ENSMUST00000101367.2
|
5'-nucleotidase, cytosolic III |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 3.6 | GO:0007144 | female meiosis I(GO:0007144) |
0.5 | 2.9 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.6 | 2.3 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.2 | 2.0 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.6 | 1.9 | GO:1904732 | elastin biosynthetic process(GO:0051542) regulation of electron carrier activity(GO:1904732) regulation of cytochrome-c oxidase activity(GO:1904959) |
0.6 | 1.9 | GO:0050925 | negative regulation of negative chemotaxis(GO:0050925) |
0.4 | 1.8 | GO:0042117 | monocyte activation(GO:0042117) |
0.1 | 1.6 | GO:0046085 | adenosine metabolic process(GO:0046085) |
0.2 | 1.5 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.1 | 1.5 | GO:0097186 | amelogenesis(GO:0097186) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 4.5 | GO:0000922 | spindle pole(GO:0000922) |
0.1 | 2.9 | GO:0031527 | filopodium membrane(GO:0031527) |
0.2 | 2.0 | GO:0001939 | female pronucleus(GO:0001939) |
0.0 | 1.9 | GO:0030673 | axolemma(GO:0030673) |
0.2 | 1.8 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 1.8 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.0 | 1.7 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.2 | 1.4 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 1.4 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.0 | 1.4 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 3.0 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.4 | 2.9 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.0 | 2.5 | GO:0097472 | cyclin-dependent protein kinase activity(GO:0097472) |
0.3 | 2.3 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.2 | 2.2 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.5 | 1.9 | GO:0004008 | copper-exporting ATPase activity(GO:0004008) copper-transporting ATPase activity(GO:0043682) |
0.3 | 1.9 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.2 | 1.9 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.0 | 1.8 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.3 | 1.6 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 4.0 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.1 | 3.8 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.4 | 3.6 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.1 | 2.4 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
0.0 | 1.8 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 1.6 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.0 | 1.6 | PID PLK1 PATHWAY | PLK1 signaling events |
0.0 | 1.4 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 1.3 | PID ARF6 PATHWAY | Arf6 signaling events |
0.0 | 1.1 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 4.3 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
0.1 | 2.6 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.1 | 1.9 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.1 | 1.8 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.1 | 1.6 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
0.0 | 1.6 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 1.4 | REACTOME EGFR DOWNREGULATION | Genes involved in EGFR downregulation |
0.0 | 1.4 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.1 | 1.3 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 1.3 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |